Lifitegrast Eye Drops are clinically commonly used drugs for treating the signs and symptoms of dry eye disease, and they have certain therapeutic effects in clinical practice. However, patients may experience some adverse drug reactions during the actual medication process, which are detailed as follows.
What are the adverse reactions of Lifitegrast Eye Drops?
When patients use Lifitegrast for treatment, they may experience adverse reactions such as instillation site irritation, taste disturbance, and decreased vision due to the drug.
Instillation site irritation
The most common adverse reaction when patients use Lifitegrast for treatment is instillation site irritation, and many patients may experience this. Patients are advised to keep in close contact with their doctors during the medication period to ensure medication safety.
Taste disturbance
Lifitegrast may also cause taste disturbance in patients. If patients experience obvious taste disturbance during the medication period, they should immediately contact their attending doctor and adjust the medication plan according to the doctor's guidance.
Decreased vision
If patients experience decreased vision while using Lifitegrast, they should stop using the eye drops under the guidance of a doctor and formulate a new treatment plan based on the doctor's diagnosis of their condition.
It should be noted that the side effects of the drug may vary depending on the patient's physical constitution and condition. When using Lifitegrast Eye Drops, patients should strictly follow the doctor's advice and medication instructions to ensure the safety and effectiveness of the medication.
Which special groups of people need to pay attention when using Lifitegrast?
Lifitegrast is clinically commonly used to treat the signs and symptoms of dry eye disease. The following groups of people should use it with caution to ensure medication safety.
Lactating women
There are currently no data on the presence of Lifitegrast in human milk. Lactating women should carefully consider when using Lifitegrast. If it is necessary to use it, they should consult a doctor and weigh the benefits of breastfeeding for the baby's development and health against the mother's clinical need for Lifitegrast.
Pediatric patients
The safety and efficacy of Lifitegrast in pediatric patients under 17 years of age have not been established, so it is not recommended for children to use it.
Elderly patients
No overall differences in safety or effectiveness have been observed between elderly and younger adult patients, so elderly patients can use Lifitegrast as recommended by their doctors.
[Warm Reminder] Special groups of people using Lifitegrast should follow the doctor's advice and pay attention to the safety and effectiveness of the drug.
